Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ningmitai capsule for chronic prostatitis
ChiCTR2000030514Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ningmitai in chronic prostatitis (CP) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: NIH-CPSI score. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
ningmitai
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on ChiCTR2000030514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030514.